Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Leukemia, Myeloid, Acute 187 Myelodysplastic Syndromes 82 Leukemia 39 Leukemia, Myelomonocytic, Chronic 36 Recurrence 24 Myeloproliferative Disorders 15 Congenital Abnormalities 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Lymphoma, Large B-Cell, Diffuse 13 Neoplasms 11 Primary Myelofibrosis 9 Melanoma 9 Blast Crisis 9 Thrombocythemia, Essential 7 Polycythemia Vera 7 Leukemia, Myelomonocytic, Acute 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Leukemia, Monocytic, Acute 7 Hodgkin Disease 7 Carcinoma, Non-Small-Cell Lung 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Ovarian Neoplasms 6 Myelodysplastic-Myeloproliferative Diseases 6 Anemia, Refractory, with Excess of Blasts 6 Neoplasm Metastasis 5 Lymphoma 5 Leukemia, Myeloid, Accelerated Phase 5 Leukemia, Biphenotypic, Acute 5 Lymphoma, Non-Hodgkin 4 Lung Neoplasms 4

Interventions

Paclitaxel 1 Decitabine 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Primary Malignant Neoplasm of Ovary × Decitabine × Clear all

NCT02159820 2014-06-10

DAC and CT

Chinese PLA General Hospital

Phase 2/3 Unknown

Primary Malignant Neoplasm of Ovary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡